1.Current Status and Strategies of Integrated Traditional Chinese and Western Medicine in the Treatment of Helicobacter pylori Infection
Xuezhi ZHANG ; Xia DING ; Zhen LIU ; Hui YE ; Xiaofen JIA ; Hong CHENG ; Zhenyu WU ; Xudong TANG
Journal of Traditional Chinese Medicine 2026;67(1):111-116
This paper systematically reviews the current status of integrated traditional Chinese and western medicine in the treatment of Helicobacter pylori (Hp) infection, as well as recent progress in clinical and basic research both in China and internationally. It summarizes the advantages of traditional Chinese medicine (TCM) in Hp infection management, including improving Hp eradication rates, enhancing antibiotic sensitivity, reducing antimicrobial resistance, decreasing drug-related adverse effects, and ameliorating gastric mucosal lesions. These advantages are particularly evident in patients who are intolerant to bismuth-containing regimens, those with refractory Hp infection, and individuals with precancerous gastric lesions. An integrated, whole-process management approach and individualized, staged comprehensive treatment strategies combining TCM and western medicine are proposed for Hp infection. Future prevention and control of Hp infection should adopt an integrative Chinese-western medical strategy, emphasizing prevention, strengthening primary care, implementing proactive long-term monitoring, optimizing screening strategies, and advancing the development of novel technologies and mechanistic studies of Chinese herbal interventions. These efforts aim to provide a theoretical basis and practical pathways for the establishment and improvement of Hp infection prevention and control systems.
2.Evaluation of host nucleic acid removal and pathogen enrichment methods in animal tissue samples
Xuezhi HUANG ; Zuming ZHANG ; Hao ZHOU ; Ting ZHAO ; Zirui XIONG ; Guangqian PEI ; Yunfei WANG ; Mengnan CUI ; Yan GUO ; Haifeng PAN ; Yujun CUI ; Hang FAN
Chinese Journal of Zoonoses 2025;41(7):682-690
This study was aimed at investigating the effectiveness of various host nucleic acid removal and non-specific amplifica-tion techniques in animal tissue samples,to increase the accuracy of pathogen identification in tissue samples.Simulated samples were prepared with a mixture of mouse lung tissue homogenates and Klebsiella pneumoniae fluids,and processed with six host nucleic acid removal kits and three non-specific amplification techniques.The effectiveness of each method in removing host DNA and enriching nucleic acids of pathogenic microorganisms was evaluated through real-time fluorescence quantitative PCR and high-throughput se-quencing.For host nucleic acid removal techniques,the method of selective cleavage and quantitative degradation of host DNA(Com-plete5 kit)effectively decreased the host nucleic acid content in tissue samples and increased the relative abundance of pathogen nucleic acids.In contrast,the magnetic bead method for host DNA removal(Next microbiome DNA enrichment Kit kit)was less effec-tive.At lower pathogen concentrations(77 CFU/mL),the Vazyme kit was more effective than the other kits in removing host nucleic acids.Non-specific amplification techniques(MALBAC whole genome amplification,MDA isothermal amplification,and random primer amplification)were not applicable to tissue samples and were not effective in increasing the relative abundance of pathogen nucleic acids.Selective lysis and quantitative degradation of host DNA were suitable for processing tissue samples with high host back-ground and low pathogenic microorganism levels,whereas non-specific amplification methods were not applicable to tissue samples for pre-processing of macro-genome high-throughput sequencing.
3.Research progress of fibroblast activation protein-targeted radiopharmaceuticals in tumor radionuclide internal radiation therapy
Xuezhi LIN ; Haiwen LU ; Guojian ZHANG
Chinese Journal of Nuclear Medicine and Molecular Imaging 2025;45(7):435-440
Fibroblast activation protein (FAP), highly expressed in cancer-associated fibroblasts, is closely related to changes in the tumor microenvironment. Radionuclide-labeled FAP inhibitor (FAPI) is a novel tumor therapeutic agent targeting FAP. It can specifically bind to FAP and emit radiation-killing signals, and has been gradually applied to tumor radionuclide internal radiation therapy (IRT). This review summarizes the research progress of various FAP-targeted radiopharmaceuticals in tumor radionuclide IRT, aiming to gain a deeper understanding of their intrinsic properties and promote broader clinical applications.
4.Research progress on the application of fibroblast activation protein inhibitor PET/CT imaging in the diagnosis and treatment of bone and joint diseases
Chinese Journal of Nuclear Medicine and Molecular Imaging 2025;45(2):120-124
Fibroblast activation protein (FAP) is overexpressed not only in cancer-associated fibroblasts, but also in bone and joint diseases. With the continuous expansion of the application range of radionuclide labeled FAP inhibitor (FAPI) PET/CT imaging, it has gradually shown a good potential in the clinical diagnosis and efficacy evaluation of bone and joint diseases. This paper reviews the animal and clinical studies of radionuclide-labeled FAPI PET/CT imaging in the diagnosis and treatment of bone and joint diseases like tumors, inflammation, Erdheim-Chester disease (ECD) and so on, aiming to further explore the characteristics of FAPI and expand the scope of clinical application.
5.Application of 18F-MFBG PET/CT imaging in the diagnosis and treatment of neural crest-derived tumors
Xuezhi LIN ; Haibo LIU ; Guojian ZHANG
Chinese Journal of Nuclear Medicine and Molecular Imaging 2025;45(9):571-576
The human norepinephrine transporter(hNET)is expressed in neural crest-derived tumors, such as neuroblastoma, pheochromocytoma, and paraganglioma. 18F-meta-fluorobenzylguanidine (MFBG) has high affinity and specificity for hNET, and has been gradually applied to PET/CT imaging in neural crest-derived tumors. The application of 18F-MFBG PET/CT imaging in the diagnosis and treatment of neural crest-derived tumors is reviewed in this article.
6.Application and value of PET imaging with molecular probes targeting TSPO in cardiovascular diseases
Chinese Journal of Nuclear Medicine and Molecular Imaging 2025;45(11):694-699
Molecular probes targeting the 18×10 3 translocator protein (TSPO) have the ability to identify and monitor tissue inflammation. Their application has expanded from neurological disorders to cardiovascular diseases (CVD), showing promising clinical translational potential in both diagnosis and therapeutic evaluation. This paper introduces the application and value of PET imaging using various generations of TSPO-targeted molecular probes in CVD, including atherosclerosis, acute myocardial infarction, large vessel vasculitis, and others.
7.Research progress on the molecular mechanism and therapeutic targets of ferroptosis in acute kidney injury
Yang ZHANG ; Fanyi HE ; Kongchun SUN ; Rui YANG ; Xuezhi YU ; Ling ZHANG ; Ruixiang CHEN ; Baochun SHEN
Organ Transplantation 2025;16(2):315-321
Acute kidney injury (AKI) is one of the most common and severe nephropathy syndromes in clinical practice and also one of the most common serious complications after organ transplantation, with high incidence and fatality. Iron is an essential trace element in the body. Ferroptosis is a form of programmed cell death induced by the accumulation of iron-mediated lipid peroxidation, and its occurrence is closely related to iron metabolism, lipid metabolism, amino acid metabolism and multiple signaling pathways. Recent studies have shown that ferroptosis plays a key role in the occurrence and development of AKI and provides therapeutic targets for AKI. This article summarizes the regulatory mechanism of ferroptosis and its role in AKI, as well as the compounds that play an important role in the prevention and treatment of AKI by inhibiting ferroptosis, providing new ideas for the future treatment and research of AKI.
8.Effects of miR-206 on LPS-induced apoptosis and inflammatory response in H9c2 cardiomyocytes
Xuezhi WANG ; Tao YUAN ; Zhenkun XU ; Shuxian GAO ; Man ZHANG
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2025;27(10):1413-1418
Objective To investigate the effect of miR-206 on LPS-induced apoptosis and inflamma-tory response in H9c2 cardiomyocytes.Methods An inflammatory injury model was established in H9c2 cells with treatment of 10 μg/ml LPS.Then the cells were divided into control group,LPS group,LPS1 group(LPS+anti-negative control),LPS2 group(LPS+anti-miR-206),LPS3 group(LPS+miR-206 negative control),and LPS4 group(LPS+miR-206 mimic).The LPS1,LPS2,LPS3,and LPS4 groups(n=3)were transfected with anti-negative control,anti-miR-206 se-quence,miR-negative control,or miR-206 mimic sequence,using Lipofectamine 3000 reagent.CCK-8 and EdU assays were used to detect cell proliferation,Caspase-Glo 3/7 activity kit was em-ployed to measure Caspase-3/7 activity,and ELISA was utilized to test the secretion of inflamma-tory cytokines,TNF-α,IL-1β,and IL-6 in the cells.Results Compared with the control group,the LPS group had significantly reduced cell survival rate and EDU-positive cell rate,while elevated miR-206 expression,Bax/Bcl-2,activated Caspase-3,Caspase-3/7,TNF-α,IL-1β,IL-6,p-p38 and p-p65(P<0.05,P<0.01).The expression of miR-206,Bax/Bcl-2,activated Caspase-3,Caspase-3/7,TNF-α,IL-1β,IL-6,p-p38 and p-p65 were obviously reduced,while the cell survival rate and EDU-positive cell rate were notably increased in the LPS 2 group than the LPS group(P<0.05).In the LPS 4 group,the activity of Caspase-3/7 was remarkably stronger than the LPS group(1586±58 vs 816±51,P<0.05).Conclusion Suppression of miR-206 can effectively inhibit LPS-induced apoptosis and inflammatory response in H9c2 cardiomyocytes.
9.Exploration on Fine Operation Management of Low Value Consumables under SPD Management Model
Hong-bin WANG ; Yi XU ; Qing ZHENG ; Xuezhi HONG ; Chunrong TAN ; Yongqin ZHANG ; Li WANG ; Jinxia ZHANG
Chinese Health Economics 2025;44(9):80-83
Objective:To strengthen the management of low-value consumables in public hospitals by introducing the Supply Processing Distribution(SPD)management model,and to explore refined operational management strategies and path optimization for low-value consumables.Methods:The SPD management model was introduced,and the entire process of hospital consumables was refinedly managed using third-party supply chain information management platforms,visualized tertiary department warehouses,Radio Frequency Identification(RFID)technology and intelligent cabinet systems,Unique Device Identification(UDI)coding,"four-code integration"and other supporting technologies.Results:Based on the analysis of the current situation in the target Hospital,specific measures related to the management of low-value consumables were introduced after the introduction of the SPD model.Conclusion:It provides a reference and guidance for the hospital's medical consumables management department to promote refined management of medical consumables under the SPD model.
10.Application of virtual reality technology in preoperative anxiety of patients with hand trauma
Fei RUI ; Xuezhi WANG ; Yingyan ZHANG ; Leiyin MAO
Chinese Journal of Practical Nursing 2025;41(15):1137-1142
Objective:To explore the application effect of virtual reality technology in preoperative anxiety of patients with hand trauma, aiming to improve the negative psychological state of patients before surgery.Methods:A prospective non-randomized controlled trial was conducted. A convenience sampling method was used to select 116 patients with hand trauma who underwent surgical treatment at Wuxi Ninth People′s Hospital from January 2022 to December 2023 as the research subjects. They were divided into an intervention group and a control group according to the treatment time, with 58 cases in each group. The control group received routine nursing intervention, while the intervention group received nursing intervention based on virtual reality technology in addition to the routine care. The preoperative anxiety, uncertainty of illness and subjective well-being of the two groups were compared before and after the intervention.Results:Three cases dropped out in the control group and six in the intervention group, with 55 and 52 patients completing the study in the control and intervention groups, respectively. In the control group, there were 29 males and 26 females, with an age of (40.60 ± 2.09) years. In the intervention group, there were 32 males and 20 females, with an age of (41.27 ± 10.55) years. After the intervention, the scores of the Self-Rating Anxiety Scale and the Uncertainty in Illness Scale in the intervention group were 52.81 ± 5.47 and 62.87 ± 4.26, respectively, which were lower than those in the control group 58.20 ± 7.29 and 67.41 ± 4.15, with statistically significant differences ( t=-4.31, -5.60, both P<0.05). The Index Well-Being score of the intervention group was 7.17 ± 1.15, higher than that of the control group 6.09 ± 0.57, with a statistically significant difference ( t=6.19, P<0.05). Conclusions:Virtual reality technology can effectively alleviate preoperative anxiety, reduce the uncertainty of illness and enhance subjective well-being in patients with hand trauma, which is beneficial to the physical and mental health of patients.

Result Analysis
Print
Save
E-mail